WOOJUNG BIO, Inc. (KOSDAQ:215380)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,015.00
-95.00 (-3.05%)
At close: Apr 28, 2026

WOOJUNG BIO Revenue

In the year 2025, WOOJUNG BIO had annual revenue of 37.59B KRW, down -12.99%. WOOJUNG BIO had revenue of 12.43B in the quarter ending December 31, 2025, with 3.88% growth.

Revenue
37.59B
Revenue Growth
-12.99%
P/S Ratio
1.35
Revenue / Employee
n/a
Employees
n/a
Market Cap
50.74B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202537.59B-5.61B-12.99%
Dec 31, 202443.20B4.58B11.87%
Dec 31, 202338.62B-8.30B-17.70%
Dec 31, 202246.92B15.68B50.20%
Dec 31, 202131.24B-6.11B-16.35%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
C&R Research 64.98B
DT&CRO CO. 47.75B
P&K Skin Research Center 22.78B
SLS BIO 3.98B
HLB bioStep 74.05B
DreamCIS 66.63B
BioInfra 23.15B
Curachem 6.02B
Revenue Rankings